changes in the classification of dlbcl
Published 4 years ago • 110 plays • Length 7:16Download video MP4
Download video MP3
Similar videos
-
1:02
the changing standard of care in dlbcl
-
2:27
elucidating the genetic and molecular basis of dlbcl
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
1:45
improving the frontline treatment of dlbcl
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
4:46
current treatment options for older patients with dlbcl
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
12:05
how to clean/change biobase hematology valves
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:45
mrd: a prognostic marker in targeted therapy
-
5:40
developments in b-cell lymphoma management
-
2:03
novel treatment approaches for early-stage dlbcl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
2:28
treatment approaches for patients with r/r dlbcl: uk perspective
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
3:02
new technologies informing soc in dlbcl
-
2:29
the management of dlbcl and the importance of characterizing molecular subtypes